Citation Impact
Citing Papers
Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting
2012
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Comparative study on transradial versus transfemoral approach for primary percutaneous coronary intervention in Chinese patients with acute myocardial infarction.
2010
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction
2002
Abciximab as Adjunctive Therapy to Reperfusion in Acute ST-Segment Elevation Myocardial Infarction
2005
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
2003 Standout
Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial
2009
Direct Cell Surface Modification with DNA for the Capture of Primary Cells and the Investigation of Myotube Formation on Defined Patterns
2009 StandoutNobel
Imaging microvascular obstruction and its clinical significance following acute myocardial infarction
2006
Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial
2002
Thrombocytopenia after abciximab use results from different mechanisms
2010
Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
Universal Definition of Myocardial Infarction
2007 Standout
High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET study
2011
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes
2005 Standout
Use of doping agents, particularly anabolic steroids, in sports and society
2008 Standout
Bivalirudin during Primary PCI in Acute Myocardial Infarction
2008 Standout
Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials
2004
Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction
2006 Standout
A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Intravenous MCC-135 as an Adjunct to Primary Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction: Rationale and Design of the Evaluation of MCC-135 for Left Ventricular Salvage in Acute MI (EVOLVE) Study
2005
Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts
2004 StandoutNature
Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration
2003 Standout
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
2013 Standout
Comparison of Angioplasty with Stenting, with or without Abciximab, in Acute Myocardial Infarction
2002
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial
2008
Acute myocardial infarction
2008
Prasugrel 5 mg in the Very Elderly Attenuates Platelet Inhibition But Maintains Noninferiority to Prasugrel 10 mg in Nonelderly Patients
2013 StandoutNobel
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial
2011 Standout
Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials
2006
Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction
2010
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials
2015
Intracoronary verapamil for reversal of no‐reflow during coronary angioplasty for acute myocardial infarction
2002
Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials
2009
Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention
2004
Current incidence and clinical outcomes of bivalirudin administration among patients undergoing primary coronary intervention for stent thrombosis elevation acute myocardial infarction
2007
The Harmonizing Outcomes with RevascularIZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: Study design and rationale
2008
Mechanical Reperfusion in Patients With Acute Myocardial Infarction Presenting More Than 12 Hours From Symptom Onset<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2005
Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention
2001
Guidelines for Percutaneous Coronary Interventions
2005
Randomized Early Versus Late Abciximab in Acute Myocardial Infarction Treated With Primary Coronary Intervention (RELAx-AMI Trial)
2007
Sex-Based Analysis of Outcome in Patients With Acute Myocardial Infarction Treated Predominantly With Percutaneous Coronary Intervention
2002
Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals
2017 Standout
Myocardial Reperfusion Injury
2007 Standout
Transcoronary Transplantation of Progenitor Cells after Myocardial Infarction
2006 Standout
Rheolytic Thrombectomy With Percutaneous Coronary Intervention for Infarct Size Reduction in Acute Myocardial Infarction
2006
Early vs Late Administration of Glycoprotein IIb/IIIa Inhibitors in Primary Percutaneous Coronary Intervention of Acute ST-Segment Elevation Myocardial Infarction
2004
Cardiac protection during acute myocardial infarction: Where do we stand in 2004?
2004
Abciximab
2003
Percutaneous coronary intervention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease?
2009
No-reflow phenomenon and prognosis in patients with acute myocardial infarction
2006
Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial
2004
Effect of Early, Pre-Hospital Initiation of High Bolus Dose Tirofiban in Patients With ST-Segment Elevation Myocardial Infarction on Short- and Long-Term Clinical Outcome
2010
Association between hyperglycemia and the no-reflow phenomenon inpatients with acute myocardial infarction
2002
Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction
2004
Antithrombotic Therapy During Percutaneous Coronary Intervention
2004
Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial
2004 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
The Optimal Route of Administration of the Glycoprotein IIb/IIIa Receptor Antagonist Abciximab During Percutaneous Coronary Intervention; Intravenous Versus Intracoronary
2008
Intracoronary application of abciximab in patients with ST-elevation myocardial infarction
2008
Cardiomyopathy induced by performance enhancing drugs in a competitive bodybuilder
2005
Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial
2006
Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up
2007
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations
2015 Standout
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Cardiogenic Shock
2008
Therapeutic Potential of Platelet Glycoprotein IIb/IIIa Receptor Antagonists in the Management of Ischemic Stroke
2003
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
MRI-guided, open trial of abciximab for ischemic stroke within a 3- to 24-hour window
2005
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome
2011
Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy
2008 Standout
Platelet function profiles in the elderly: Results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivity
2011
Abciximab-Supported Infarct Artery Stent Implantation for Acute Myocardial Infarction and Long-Term Survival
2004
Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors
2003 Standout
Abciximab in Patients With Acute ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention After Clopidogrel Loading
2009
Therapeutic Angiogenesis
2006 StandoutNobel
The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes
2006
Microvasculature in Acute Myocardial Ischemia: Part II
2004
Outcome in Elderly Patients Undergoing Primary Coronary Intervention for Acute Myocardial Infarction
2004
Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure
2003 Standout
Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)
2002 Standout
Clinical Applications of Stem Cells for the Heart
2005
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Reduction of Major Adverse Cardiac Events With Intracoronary Compared With Intravenous Bolus Application of Abciximab in Patients With Acute Myocardial Infarction or Unstable Angina Undergoing Coronary Angioplasty
2003
Clinical Aspects of Platelet Inhibitors and Thrombus Formation
2007
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Endothelial Progenitor Cells
2004 Standout
Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction
2003 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
2004 Standout
Impact of Prior Use or Recent Withdrawal of Oral Antiplatelet Agents on Acute Coronary Syndromes
2004
Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells
2004 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Works of Simon Elhadad being referenced
Randomized comparison of platelet function monitoring to adjust antiplatelet therapy versus standard of care: Rationale and design of the Assessment with a double Randomization of (1) a fixed dose versus a monitoring-guided dose of aspirin and Clopidogrel after DES implantation, and (2) Treatment Interruption versus Continuation, 1 year after stenting (ARCTIC) study
2010
Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial Infarction
2001
Primary stenting with abciximab in acute myocardial infarction complicated by cardiogenic shock (the ADMIRAL trial)
2002